Please find attached my issues sheet on package 6. This is being submitted without withdrawing my arguments that this “can’t live with” exercise is inconsistent with GNSO operating
procedures and smacks of early consensus calling before the consensus call. Thanks!
Best,
Paul
To receive regular COVID-19 updates from Taft, subscribe
here. For additional resources, visit Taft's COVID-19
Resource Toolkit.
This message may contain information that is attorney-client privileged, attorney work product or otherwise confidential. If you are not an intended recipient, use and disclosure of this message are prohibited. If you received this transmission in error, please
notify the sender by reply e-mail and delete the message and any attachments.
From: Gnso-newgtld-wg <gnso-newgtld-wg-bounces@icann.org>
On Behalf Of Susan Payne
Sent: Tuesday, June 30, 2020 4:03 PM
To: Emily Barabas <emily.barabas@icann.org>; gnso-newgtld-wg@icann.org
Subject: Re: [Gnso-newgtld-wg] Deadline 30 June - Comments on Revised Draft Recommendations - Package 6
Please find attached my issues sheet on package 6.
Susan Payne
Head of Legal Policy
Valideus
D: +44 (0) 20 7421 8255
E: susan.payne@valideus.com
From: Gnso-newgtld-wg <gnso-newgtld-wg-bounces@icann.org>
On Behalf Of Emily Barabas
Sent: 19 June 2020 20:14
To: gnso-newgtld-wg@icann.org
Subject: [Gnso-newgtld-wg] Deadline 30 June - Comments on Revised Draft Recommendations - Package 6
Dear all,
The leadership team is releasing the
sixth set of revised draft recommendations for your review.
·
2.2.4 Different TLD Types (last discussed on
23 Apr)
·
2.2.8 Conflicts of Interest (this is new section, but the recommendation contained in it was discussed on
9 Apr under topic Objections)
·
2.6.1 Application Queuing (last discussed on
8 Jun)
·
2.7.3 Closed Generics (last discussed on
14 May)
·
2.8.1 Objections (last discussed on
9 Apr)
·
2.9.1 Community Applications (last discussed on
8 Jun)
Kind regards,
Emily
The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended
recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that the Com Laude Group does not accept any responsibility
for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities.
The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England
and Wales with company number 06181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176, having its registered office at 33 Melville Street, Edinburgh,
Lothian, EH3 7JF Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, headquartered at 1751 Pinnacle Drive, Suite 600, McLean, VA 22102, USA; Com Laude (Japan) Corporation, a company registered in Japan having its registered office at Suite 319,1-3-21
Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan. For further information see
www.comlaude.com